| Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
|---|
| 03/08/2006 | CN1244583C Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives, its synthesizing method and application in producing anticancer preparation |
| 03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/08/2006 | CN1244322C Use of inhibitors of sodium-hydrogen exchanging pump for production of medicine for treatment of disorders which are caused by protozoa |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7008753 Optical recording medium |
| 03/02/2006 | WO2006023889A2 A method for preparing irbesartan and intermediates thereof |
| 03/02/2006 | WO2006023844A2 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | CA2754633A1 A method for preparing irbesartan and intermediates thereof |
| 03/02/2006 | CA2576971A1 Compositions and methods comprising proteinase activated receptor antagonists |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628533A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/23/2006 | US20060041147 Coupling a 2-cyano-p-bromomethyl diphenyl with a 1,3-diazaspiro (4,4)nonane ring in the presence of a base, a reducing agent, and a phase transfer catalyst; angiotensin II receptor antagonist, treating cardiovascular ailments such as hypertension and heart failure |
| 02/23/2006 | US20060041134 Silyl ethers |
| 02/23/2006 | US20060040976 Thiobenzimidazole derivatives |
| 02/22/2006 | EP1626964A2 New benzimidazole derivatives |
| 02/22/2006 | EP1626717A2 Benzimidazoles, compositions containing such compounds and methods of use |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738807A Substituted aralkyl derivatives |
| 02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
| 02/21/2006 | US7002021 Diketopyrrolopyrrole pigments |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001887 Peptide derivatives |
| 02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
| 02/16/2006 | US20060035906 Converting hydroxyl group in 1-formyl-4-(2-hydroxyethyl) piperazine to a leaving group, reacting with 2-mercaptobenzimidazole , and removing the formyl group; formyl derivative is prepared by formylating 1-(2-hydroxyethyl)piperazine |
| 02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | EP1010423B1 Oral pharmaceutical preparation comprising an antiulcer benzimidazole derivative, and process for its production |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/15/2006 | CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/14/2006 | US6998486 Process for production of cyclic diamine compounds or salts thereof |
| 02/14/2006 | US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease |
| 02/14/2006 | CA2241186C Benzimidazole derivatives |
| 02/09/2006 | WO2006014134A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | WO2006013210A2 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/09/2006 | US20060030618 Vanilloid receptor ligands and their use in treatments |
| 02/09/2006 | US20060030565 Amide derivatives and nociceptin antagonists |
| 02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
| 02/09/2006 | CA2575882A1 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 02/08/2006 | EP1622884A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1). |
| 02/08/2006 | EP1622878A2 Compounds, compositions and methods |
| 02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
| 02/08/2006 | EP1183243B1 Short-acting benzodiazepines |
| 02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
| 02/08/2006 | CN1732146A Cycloalkyl inhibitors of potassium channel function |
| 02/08/2006 | CN1730482A A temodar synthesis method |
| 02/08/2006 | CN1240702C Process for extracting tetrodosin with high output rate |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | US6995154 Catalyst for joining, breaking of Dna; antitumor, anticancer agents |
| 02/02/2006 | WO2006010968A1 New aryloxy acetic acid amide derivatives |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620391A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/01/2006 | EP1341774B1 Fused heteroaromatic glucokinase activators |
| 02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 02/01/2006 | CN1729188A Synthesis of heteroaryl acetamides |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 02/01/2006 | CN1239478C 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 01/26/2006 | WO2005121102A3 Factor viia inhibitor |
| 01/26/2006 | US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | CA2574625A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP0978392B1 Optical recording media |
| 01/25/2006 | CN1726214A Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 01/25/2006 | CN1726194A Novel compounds |
| 01/25/2006 | CN1726031A 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines |
| 01/25/2006 | CN1238340C Alkylthio-and aryl (heteroyl) thio substituted p-phenylenediamines their manufacture and their use in rubber |
| 01/19/2006 | US20060014963 2-Oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/19/2006 | US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/18/2006 | EP1615896A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723208A Magnesium salt of imidazole derivative |
| 01/18/2006 | CN1723022A inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/12/2006 | WO2006004924A2 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613618A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |